<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Battelle on Bioecon</title><link>https://en.bioecon.ru/companies/battelle/</link><description>Recent content in Battelle on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Wed, 12 Aug 2026 22:49:49 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/battelle/index.xml" rel="self" type="application/rss+xml"/><item><title>Defense bioeconomy</title><link>https://en.bioecon.ru/technology/defense-bioeconomy/</link><pubDate>Wed, 12 Aug 2026 14:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/defense-bioeconomy/</guid><description>The government contracting and strategic-investment layer where biotechnology serves national-security ends — biodefense medical countermeasures, biological threat-reduction research, and intelligence-community venture funding of dual-use biotech — distinct from the commercial biosecurity-screening tools and civilian biomanufacturing this platform covers elsewhere.</description></item><item><title>DNA synthesis biosecurity screening</title><link>https://en.bioecon.ru/technology/dna-synthesis-biosecurity-screening/</link><pubDate>Sun, 09 Aug 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/dna-synthesis-biosecurity-screening/</guid><description>Screening every DNA and RNA synthesis order against a curated database of dangerous pathogen and toxin sequences before it is manufactured — commercial compliance-automation platforms and cryptographically privacy-preserving nonprofit screening tools that gene-synthesis providers like Twist Bioscience now run on every incoming order, driven by an October 2026 US regulatory deadline dropping the flagging threshold to 50 base pairs.</description></item></channel></rss>